Added to YB: 2020-09-06
Pitch date: 2020-09-06
ALXN [bullish]
Alexion Pharmaceuticals, Inc.
+63.35%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alexion Pharmaceuticals, Inc. is engaged in the research, development, and delivery of therapies and medicines for rare diseases.
Market Cap
$40.3B
Pitch Price
$111.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
59.23
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ALEXION PHARMACEUTICALS INC ALXN
A summary for this pitch has not been created yet.
Read full article (0 min)